logo
Top Stories
56
45
GM-Recall-111717-lg.jpg

General Motors Co. (GM) is recalling nearly 49,000 trucks worldwide to fix a fuel tank issue that can increase the risk of a fire. The recall covers Chevrolet Silverado 3500 and GMC Sierra 3500 trucks from the 2011 through 2015 model years, all equipped...

HousingStarts-111717-lg.jpg

New residential construction in the U.S. jumped by much more than expected in the month of October, according to a report released by the Commerce Department on Friday. The report said housing starts spiked by 13.7 percent to an annual rate of 1.290...

US-Military-Gen-Dunford-111717-lg.jpg

The Chairman of the Joint Chiefs of Staff (CJCS) has warned that the United States' military advantage against near-peer competitors Russia and China is eroding, and it is no longer as decisive as it was some years ago. General Joseph Dunford sounded...

wallstreet4-103112_17Nov17.jpg

While selling pressure was relatively subdued, stocks saw modest weakness during trading on Friday. The major averages all moved to the downside, with the tech-heavy Nasdaq pulling back off the record closing high set in the previous session.

Shakira-111517-lg.jpg

Shakira has announced that she is postponing her European tour until next year to rest and fully recover from a hemorrhage on her vocal cords. The pop diva is disappointing thousands of her fans days after announcing the cancellation of her El Dorado...

Pharma-110817.jpg Shares of Stemline Therapeutics Inc. (STML), which have gained an impressive 80% in the last three months, are hovering around their 52 week high mark.
The biennial Dubai Air Show opened Sunday with Emirates placing a preliminary order worth $15 billion for 40 787-10 Dreamliners from Boeing. Emirates Chairman Sheikh Ahmed bin Saeed al-Maktoum said the aircraft had been chosen over the Airbus A350....
Hasbro Inc. (HAS) has reportedly offered to acquire its key rival Mattel Inc. (MAT), a merger deal that could combine the two biggest toy makers in the U.S. According to a report on the WSJ, Hasbro had recently approached Mattel with the deal. However,...
Pharma-111017.jpg Today's Daily Dose brings you news about Arena's progress in phase II study of Etrasimod in ulcerative colitis; expanded FDA approval of Bristol-Myers' leukemia drug Sprycel; voluntarily delisting of Mylan's ordinary shares from the Tel Aviv Stock Exchange and Vanda's disappointment over Fanaptum's failure to win the CHMP's backing.
More
AlexAzar-111317.jpg President Donald Trump announced Monday he is nominating former pharmaceutical company executive Alex Azar as secretary of the U.S. Health and Human Services Department. Azar, a prominent Obamacare critic, previously served as president of Lilly USA,...
More
OrrinHatch-111717.jpg Republican members of the Senate Finance Committee voted Thursday to approve their version of tax reform legislation. The committee voted 14 to 12 in favor of the $1.5 trillion tax reform bill, with the vote coming down strictly along party lines....
More
Malaysia-GDP-Q3-111717.jpgMalaysia's economy expanded at the fastest pace in more than three years in the third quarter on private spending and foreign demand. Gross domestic product rose 6.2 percent year-on-year, faster than the 5.8 percent increase seen in the second quarter, data from the Department of Statistics showed Friday.
More
BillGates-CuringAlzheimers-111317.jpg
Billionaire and Microsoft co-founder Bill Gates is making a personal investment of $50 million into the Dementia Discovery Fund, a venture capital fund that invests in projects and companies to develop treatments for the brain-wasting disease. The investment is not part of Gates' philanthropic Bill & Melinda Gates Foundation, which has focused primarily on infectious diseases.
More
The Swiss stock market ended Friday's session with a small increase, bucking the overall trend in Europe. The market ended the trading week with a small gain, after ending the previous week lower. Reports that Special Counsel Robert Mueller issued subpoenas to over a dozen top Trump campaign officials...
Trafon-Recalls-Chicken-Pork-111717.jpg
Trafon Group, a Puerto Nuevo, P.R. establishment, is recalling approximately 297,828 pounds of chicken and pork products that were not presented at the U.S. point-of-entry for inspection. FSIS personnel discovered this problem on Nov. 10, 2017 while performing routine import verification activities. There have been no confirmed reports of adverse reactions due to consumption of these products.
More
Today's Daily Dose brings you news about Aerie's progress in phase II trial of glaucoma drug in Japan; phase III results of Egalet's pain pill; FDA approval of GlaxoSmithKline's COPD drug; expanded labeling for Pfizer's kidney cancer drug Sutent and Roche's double blessing on Thursday. More
If the timeline is adhered to, this clinical-stage company, focused on developing drugs for disorders concerned especially with the ear, nose, and throat, has an important catalyst coming up this quarter. More
HealthIQ-111517.jpg Health IQ Insurance Services, a startup focused on providing life insurance for health-conscious individuals, said it has secured $34.6 million in Series C funding, led by Andreessen Horowitz. To date, the company has raised a total of $81 million in funding mostly from its existing investors.
More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
11/17/17 13:0Baker Hughes - Rig CountNOV 17 United States
11/17/17 10:30CB Coincidence IndexSEP Australia
11/17/17 10:30CB Leading IndexSEP Australia
11/17/17 9:30CB Coincidence IndexSEP France
11/17/17 9:30CB Leading IndexSEP France
11/17/17 8:30Core CPI (M-o-M)OCT Canada
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
02/14/18AMAG, AMAGMakena subcutaneous auto-injector (sNDA)FDA decision on subcutaneous version of Makena to reduce the risk of preterm birth
01/24/18SGYPTRULANCE (sNDA)FDA decision on TRULANCE for the treatment of adults with irritable bowel syndrome with constipation
01/12/18LGNDLUXTURNA (BLA)FDA decision on LUXTURNA for inherited retinal disease
01/12/18ONCELUXTURNA (BLA)FDA decision on LUXTURNA for treatment of patients with vision loss due to confirmed biallelic RPE65 mutation-associated retinal dystrophy.
01/10/18LLYAbemaciclib (NDA)FDA decision on Abemaciclib for the treatment of advanced breast cancer
Complete FDA Calendar